Mucocutaneous paraneoplastic syndromes in hematologic malignancies

International Journal of Dermatology

Volumn 45, Issue 1, 2006, Pages 14-22

  Zappasodi, Patrizia ^a   Del Forno, Corrado ^a   Corso, Alessandro ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BULLOUS PEMPHIGOID ANTIGEN 1; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; DAPSONE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 8; METHOTREXATE; POTASSIUM IODIDE; PSORALEN; TACROLIMUS; THALIDOMIDE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; AMYLOIDOSIS; BACTERIAL INFECTION; BULLOUS SKIN DISEASE; CLINICAL FEATURE; DERMATITIS HERPETIFORMIS; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ERYTHEMA; ERYTHEMATOSQUAMOUS SKIN DISEASE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; ICHTHYOSIS; PARANEOPLASTIC SYNDROME; PEMPHIGOID; PUVA; PYODERMA GANGRENOSUM; REVIEW; SKIN TUMOR; SUBCORNEAL PUSTULAR DERMATOSIS; ULTRAVIOLET A RADIATION; VASCULITIS; BLOOD DISEASE; COMORBIDITY; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; MALE; MUCOSA; NEEDLE BIOPSY; PATHOLOGY; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SKIN DISEASE;

BIOPSY, NEEDLE; COMORBIDITY; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUCOUS MEMBRANE; PARANEOPLASTIC SYNDROMES; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN DISEASES;

EID: 33645966825     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02668.x     Document Type: Review

References (66)

1. Cohen PR, Kurzrock R. Mucocutaneous paraneoplastic syndromes. Semin Oncol 1997; 24: 334-359.
2. Cooper PH, Innes DJ, Greer KE. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and myeloproliferative disorders. Cancer 1983; 51: 1518-1526.
3. Klock JC, Oken RL. Febrile neutrophilic dermatosis in acute myelogenous leukemia. Cancer 1976; 37: 922-927.
4. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol 1988; 6: 1887-1897.
5. Cohen PR, Kurzrock R. Sweet's syndrome revisited: A review of disease concepts. Int J Dermatol 2003; 42: 761-778.
6. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964; 76: 349-356.
7. Hensley CD, Caughman SW. Neutrophilic dermatoses associated with hematologic disorders. Clin Dermatol 2000; 18: 355-367.
8. Zappasodi P, Corso A, Del Forno C. Sweet's syndrome and myelodysplasia: two entities with a common pathogenetic mechanism? Haematologica 2000; 85: 868-869.
9. Suzuki Y, Kuroda K, Kojima T, et al. Unusual cutaneous manifestations of myelodysplastic syndrome. Br J Dermatol 1995; 133: 483-486.
10. Cohen PR, Kurzrock R. Sweet's syndrome: A neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 2000; 18: 265-282.
11. Krauser RE, Schumacher HR. The arthritis of Sweet syndrome. Arthritis Rheum 1975; 18: 35-41.
12. Greer KE, Cooper PH. Sweet's syndrome (acute febrile neutrophilic dermatosis). Clin Rheumatol Dis 1982; 8: 427-441.
13. Su WPD, Liu HN. Diagnostic criteria for Sweet's syndrome. Cutis 1986; 37: 167-174.
14. Cohen PR. Sweet's syndrome. Orphanet Encyclopedia, October 2003. http://www.orpha.net/data/patho/GB/uk-Sweet.pdf.
15. Unis ME, Hill GS. Sweet's syndrome associated with acute renal failure. Cutis 1987; 40: 139-142.
16. Matta M, Malak J, Tabet E, et al. Sweet's syndrome: Systemic association. Cutis 1973; 12: 561-565.
17. Lazarus AA, McMillan M, Miramadi A. Pulmonary involvement in Sweet's syndrome (acute febrile neutrophilic dermatosis). Preleukemic and leukemic phases of acute myelogenous leukemia. Chest 1986; 90: 922-924.
18. Kurzrock R, Cohen PR. Mucocutaneous paraneoplastic manifestations in hematologic malignancy. Am J Med 1995; 99: 207-216.
19. Callen JP, Woo TY. Vesiculopustular eruption in a patient with ulcerative colitis. Pyoderma gangrenosum. Arch Dermatol 1985; 121: 399-403.
20. Lear JT, Atherton MT, Byrne LP. Neutrophilic dermatoses. Pyoderma gangrenosum and Sweet's syndrome. Postgrad Med J 1997; 73: 65-68.
21. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: Classification and management. J Am Acad Dermatol 1996; 34: 395-409.
22. Lutz ME, Daoud MS, McEvoy MT, et al. Subcorneal pustular dermatosis: A clinical study of ten patients. Cutis 1998; 61: 203-208.
23. Kasha EE Jr, Epinette WW. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) in association with a monoclonal IgA gammopathy: A report and review of the literature. J Am Acad Dermatol 1988; 19: 854-858.
24. Cohen PR, Kurzrock R. Sweet's syndrome and cancer. Clin Dermatol 1993; 11: 149-157.
25. Fett DL, Gibson LE, Su WPD. Sweet's syndrome. Systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995; 70: 234-240.
26. Aram H. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Response to dapsone. Arch Dermatol 1984; 120: 245-247.
27. Nunzi E, Crovato F, Dallegri F, et al. Immunopathological studies on a case of Sweet's syndrome. Dermatologica 1981; 163: 393-400.
28. Kaplan SS, Wechsler HL, Basford RE, et al. Increased plasma chemoattractant in Sweet's syndrome. J Am Acad Dermatol 1985; 12: 1013-1021.
29. Kemmett D, Harrison DJ, Hunter JAA. Autoantibodies to neutrophil cytoplasm antigens: A serologic marker for Sweet's syndrome. J Am Acad Dermatol 1991; 24: 967-969.
30. Cohen PR, Kurzrock R. The pathogenesis of Sweet's syndrome (letter). J Am Acad Dermatol 1991; 25: 734.
31. Reuss-Borst MA, Pawelec G, Saal JG, et al. Sweet's syndrome associated with myelodysplasia: Possible role of cytokines in the pathogenesis of the disease. Br J Haematol 1993; 84: 356-358.
32. Going JJ. Is the pathogenesis of Sweet's syndrome mediated by interleukin-1? Br J Dermatol 1987; 116: 282-283.
33. Ross HJ, Moy LA, Kaplan R, et al. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer 1991; 68: 441-443.
34. Cartier H, Plantin P, Leroy JP, et al. Pyoderma gangrenosum, pustolose sous-corneé à IgA et pleuropneumopathies neutrophiliques récidivantes chez une malade porteuse d'une gammapathie à IgA. Ann Dermatol Venereol 1995; 122: 97-101.
35. Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors: A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994; 130: 77-81.
36. Montoto S, Bosch F, Estrach T, et al. Pyoderma gangrenosum triggered by alpha 2b -interferon in a patient with chronic granulocytic leukemia. Leuk Lymphoma 1998; 30: 199-202.
37. Giasuddin AS, El-Orfi AH, Ziu MM, et al. Sweet's syndrome: Is the pathogenesis mediated by helper T cell type 1 cytokines? J Am Acad Dermatol 1998; 39: 940-943.
38. Cohen PR, Kurzrock R. Sweet's syndrome: A review of current treatment options. Am J Clin Dermatol 2002; 3: 117-131.
39. Cooley HM, Castelino D, McNair P, et al. Resolution of pyoderma gangrenosum using tacrolimus (FK-506). Aust NZ J Med 1996; 26: 238-239.
40. Stone MS, Lyckholm LJ. Pyoderma gangrenosum and subcorneal pustular dermatosis: Clues to underlying immunoglobulin A myeloma. Am J Med 1996; 100: 663-664.
41. Hashimoto T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res 2003; 295 (Suppl. 1): S2-S11.
42. O'Toole A, Mak LL, Guitart J, et al. Induction of keratinocyte IL-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol 2000; 119: 217-224.
43. Egan CA, Florell SR, Zone JJ. Localized bullous pemphigoid in a patient with B-cell lymphoma. South Med J 1999; 92: 1220-1222.
44. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. The Lancet 1999; 354: 667-672.
45. Joly P, Courville P, Lok C, et al. Clinical criteria for the diagnosis of bullous pemphigoid: A reevaluation according to immunoblot analysis of patient sera. Dermatology 2004; 208: 16-20.
46. Stanley JR. Bullous pemphigoid. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine, 6th edn. New York: McGraw-Hill, 2003: 574-581.
47. McLean DI, Haynes HA. Cutaneous manifestations of internal malignant disease: Cutaneous paraneoplastic syndromes. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Fitzpatrick's Dermatology in General Medicine, 6th edn. New York: McGraw-Hill, 2003: 1783-1796.
48. Ogawa H, Sakuma M, Morioka S et al. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci 1995; 9: 136.
49. Sigurgeirsson B, Agnarsson BA, Lindelof B. Risk of lymphoma in patients with dermatitis herpetiformis. Br Med J 1994; 308: 13-15.
50. Valente L, Velho GC, Farinha F, et al. Scleredema, acanthosis nigricans and IgA/Kappa multiple myeloma. Ann Dermatol Venereol 1997; 124: 537-539.
51. Janier M, Blanchet-Bardon C, Bonvalet D, et al. Malignant acanthosis nigricans associated with non-Hodgkin lymphoma. Report of 2 cases. Dermatologica 1988; 176: 133-137.
52. Cohen PR, Grossman ME, Silvers DN, et al. Tripe palms and cancer. Clin Dermatol 1993; 11: 165-173.
53. Cooper MF, Wilson PD, Hartop PJ, et al. Acquired ichthyosis and impaired dermal lipogenesis in Hodgkin's disease. Br J Dermatol 1980; 102: 689-693.
54. Lober CW. Should the patient with generalized pruritus be evaluated for malignancy? J Am Acad Dermatol 1988; 19: 350-352.
55. Richardson JB, Callen JP. Dermatomyositis and malignancy. Med Clin North Am 1989; 73: 1211-1220.
56. Cohen PR. Cutaneous paraneoplastic syndromes. Adv Dermatol 1995; 11: 215-252.
57. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polimyositis: A population-based study. Lancet 2001; 357: 85-86.
58. King LE, Dufresne RG, Lovett GL, et al. Erythroderma: Review of 82 cases. South Med J 1986; 79: 1210-1215.
59. Wilson DC, Jester JD, King LE. Erythroderma and exfoliative dermatitis. Clin Dermatol 1993; 11: 67-72.
60. Kurzrock R, Cohen PR. Erythromelalgia and myeloproliferative disorders. Arch Intern Med 1989; 149: 105-109.
61. Sanchez-Guerrero J, Gutierrez-Urena S, Vidaller A, et al. Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol 1990; 17: 1458 -1462.
62. Kurzrock R, Cohen PR. Vasculitis and cancer. Clin Dermatol 1993; 11: 175 -187.
63. Tschen JA. Amyloidosis and neoplasia. Clin Dermatol 1993; 11: 33-36.
64. Kyle R, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45-59.
65. McEvoy MT, Connolly SM. Linear IgA dermatosis: Association with malignancy. J Am Acad Dermatol 1990; 22: 59 -63.
66. Rook AJ, Wilkinson DS, Ebling FJG. Textbook of Dermatology, 6th edn. Oxford: Blackwell Science, 1998: 2714 -2715.